Demand for commercial lab space has skyrocketed over the last several years as more and more life sciences startups receive VC funding. The COVID-19 pandemic has placed a premium on scientific and medical lab space, particularly in geographical clusters where there is a high density of biotech and pharmaceutical companies, along with a strong innovation ecosystem and funding landscape. In this report, we devised a methodology to calculate “Market Ecosystem Scores”—a scoring system ranking the top 15 US metropolitan statistical areas (MSAs) in the life sciences space based on relative maturity, growth and industry importance.
